A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability-Reference-Cited by-同舟云学术

A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability

Published:2022-12-01 Issue:12 Volume:179 Page:892-896
ISSN:0002-953X
Container-title:American Journal of Psychiatry
language:en
Short-container-title:AJP

Author:

Barber Gregory¹,Nemeroff Charles B.¹,Siegel Steven¹

Affiliation:

1. Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Barber); Department of Psychiatry and Behavioral Sciences, Dell Medical School, University of Texas at Austin (Nemeroff); Department of Psychiatry and Behavioral Sciences, University of Southern California, Los Angeles (Siegel).

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health

Reference12 articles.

1. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

2. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences

3. Human hallucinogen research: guidelines for safety

4. Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

5. Constructing drug effects: A history of set and setting

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting;2024-08-26

2. A framework for assessment of adverse events occurring in psychedelic-assisted therapies;Journal of Psychopharmacology;2024-07-31

3. Exploring the Impact of Recreational Drugs on Suicidal Behavior: A Narrative Review;Psychoactives;2024-07-03

4. Stigma, psychedelics use, and the risk of reduced formal mental health care.;Stigma and Health;2024-06-24

5. Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and Distress;Psychoactives;2024-06-02